Table 4.

Univariate and multivariate regression analysis for the parameters affecting no reflow cases (TIMI <3).

	Univariate		Multivariate
	P-value	OR (95% C.I)	P-value	OR (95% C.I)
Age (years)	<0.001∗∗	1.072∗	0.006∗	1.115∗
		(1.050–1.093)		(1.032–1.205)
Diabetes mellitus	<0.001∗∗	2.751∗	0.04∗	4.401∗
		(1.813–4.175)		(1.081–17.923)
Hypertension	<0.001∗∗	2.954∗	0.16	2.518
		(1.946–4.484)		(0.701–9.045)
CHA2DS2VASc score	<0.001∗∗	1.759∗	0.06	0.460
		(1.496–2.067)		(0.205–1.030)
Symptoms-to-door	<0.001∗∗	1.129∗	0.16	0.335
		(1.085–1.174)		(0.073–1.543)
Time to reperfusion	<0.001∗∗	1.132∗	0.12	3.412
		(1.088–1.177)		(0.739–15.756)
KILLIP class	<0.001∗∗	3.073∗	0.79	0.845
(class I vs.class ≥ II)		(1.944–4.859)		(0.245–2.908)
CK-MB	<0.001∗∗	1.002∗	0.25	0.998
		(1.001–1.004)		(0.994–1.002)
Troponin (ng/ml)	<0.001∗∗	1.033∗	0.04∗	1.040∗
		(1.020–1.046)		(1.001–1.080)
CAR	<0.001∗∗	6.094∗	< 0.001∗∗	3.357∗
		(4.284–8.668)		(2.288–4.927)
FAR	<0.001∗∗	5.099∗	< 0.001∗∗	4.187∗
		(3.761–6.912)		(2.761–6.349)
AIP	<0.001∗∗	97.070∗	0.04∗	16.794∗
		23.312–404.196		(1.018–277.01)
Type of occlusion	<0.001∗∗	3.174∗	0.66	0.722
(total vs. subtotal occlusion)		(1.749–5.763)		(0.170–3.060)
Thrombus burden (heavy)	<0.001∗∗	8.094∗	<0.001∗∗	16.915∗
		(5.056–12.958)		(5.055–56.602)

AIP: atherogenic index of plasma; CAR: C-reactive protein to albumin ratio; C.I: confidence interval; CK-MB: creatinine kinase-MB; FAR: fibrinogen to albumin ratio; OR: odds ratio.

∗Statistically significant difference between two groups (p < 0.05).

∗∗Highly statistically significant difference between two groups (p < 0.001).